tiprankstipranks
Trending News
More News >
Cardiff Oncology, Inc. (CRDF)
NASDAQ:CRDF
US Market

Cardiff Oncology (CRDF) Income Statement

Compare
1,904 Followers

Cardiff Oncology Income Statement

Last quarter (Q3 2025), Cardiff Oncology's total revenue was $120.00K, a decrease of -27.27% from the same quarter last year. In Q3, Cardiff Oncology's net income was $-11.26M. See Cardiff Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 683.00K$ 488.00K$ 386.00K$ 359.00K$ 366.00K
Gross Profit
$ 683.00K$ 488.00K$ 386.00K$ 359.00K$ 366.00K
Operating Expenses
$ 49.33M$ 45.90M$ 40.29M$ 29.21M$ 19.45M
Depreciation and Amortization
$ 404.00K$ 398.00K$ 236.00K$ 451.00K$ 466.00K
EBITDA
$ -48.25M$ -45.01M$ -39.67M$ -28.40M$ -18.84M
Operating Income
$ -48.65M$ -45.41M$ -39.90M$ -28.86M$ -19.09M
Other Income/Expenses
$ 3.22M$ 3.97M$ 1.20M$ 564.00K$ -221.00K
Pretax Income
$ -45.43M$ -41.44M$ -38.70M$ -28.29M$ -19.31M
Net Income
$ -45.43M$ -41.44M$ -38.70M$ -28.29M$ -19.31M
Per Share Metrics
Basic EPS
$ -0.95$ -0.93$ -0.89$ -0.73$ -1.08
Diluted EPS
$ -0.95$ -0.93$ -0.89$ -0.73$ -1.08
Weighted Average Shares Outstanding
47.65M 44.68M 43.60M 39.03M 20.88M
Weighted Average Shares Outstanding (Diluted)
47.65M 44.68M 43.60M 39.03M 20.88M
Currency in USD

Cardiff Oncology Earnings and Revenue History